David G. Warnock

1979–2024 年に発表

111
論文数
27,843
被引用数
87
h 指数
111
i10 指数

被引用数

David G. Warnock の年別被引用数1981 年: 被引用 5 件1982 年: 被引用 2 件1983 年: 被引用 14 件1984 年: 被引用 6 件1985 年: 被引用 15 件1986 年: 被引用 11 件1987 年: 被引用 14 件1988 年: 被引用 12 件1989 年: 被引用 9 件1990 年: 被引用 9 件1991 年: 被引用 7 件1992 年: 被引用 4 件1993 年: 被引用 7 件1994 年: 被引用 6 件1995 年: 被引用 22 件1996 年: 被引用 34 件1997 年: 被引用 41 件1998 年: 被引用 43 件1999 年: 被引用 60 件2000 年: 被引用 61 件2001 年: 被引用 56 件2002 年: 被引用 56 件2003 年: 被引用 64 件2004 年: 被引用 81 件2005 年: 被引用 71 件2006 年: 被引用 60 件2007 年: 被引用 105 件2008 年: 被引用 173 件2009 年: 被引用 192 件2010 年: 被引用 206 件2011 年: 被引用 235 件2012 年: 被引用 316 件2013 年: 被引用 315 件2014 年: 被引用 296 件2015 年: 被引用 261 件2016 年: 被引用 288 件2017 年: 被引用 223 件2018 年: 被引用 210 件2019 年: 被引用 779 件2020 年: 被引用 797 件2021 年: 被引用 729 件2022 年: 被引用 498 件2023 年: 被引用 358 件2024 年: 被引用 572 件2025 年: 被引用 277 件2026 年: 被引用 2 件2027 年: 被引用 1 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,781 件、この内訳の 26%イギリス: 引用元論文 754 件、この内訳の 7.1%中国: 引用元論文 686 件、この内訳の 6.4%ドイツ: 引用元論文 577 件、この内訳の 5.4%イタリア: 引用元論文 557 件、この内訳の 5.2%カナダ: 引用元論文 527 件、この内訳の 4.9%フランス: 引用元論文 380 件、この内訳の 3.6%オーストラリア: 引用元論文 374 件、この内訳の 3.5%日本: 引用元論文 328 件、この内訳の 3.1%スペイン: 引用元論文 309 件、この内訳の 2.9%オランダ: 引用元論文 299 件、この内訳の 2.8%スイス: 引用元論文 262 件、この内訳の 2.4%
0%26%その他 26.7%

分野

  • Medicine76.4%
  • Biochemistry, Genetics and Molecular Biology17.7%
  • Nursing1.2%
  • Immunology and Microbiology0.9%
  • Health Professions0.6%
  • Environmental Science0.5%
  • その他2.7%

トピック

  • Acute Kidney Injury Research9.2%
  • Chronic Kidney Disease and Diabetes7.8%
  • Dialysis and Renal Disease Management5.1%
  • Ion Transport and Channel Regulation3.1%
  • Lysosomal Storage Disorders Research2.7%
  • Trauma, Hemostasis, Coagulopathy, Resuscitation2.5%
  • その他69.6%

共著者

全論文

検索で開く
  1. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

    著者: , , , , , , , - Critical Care 2007 被引用: 7,080

  2. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2015 被引用: 897

  3. The global burden of chronic kidney disease: estimates, variability and pitfalls

    著者: , , - Nature Reviews Nephrology 2016 被引用: 510

  4. Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

    著者: , , , , , , , , , , , - New England Journal of Medicine 2011 被引用: 876

  5. Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration Rate

    著者: , , , , , , , , , , , , , , , - JAMA 2012 被引用: 991

  6. Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Einat Brill‐Almon, Sari Alon, Raul Chertkoff, Rossana Rocco, Anat Sakov, David G. Warnock - Journal of Medical Genetics 2023 被引用: 43

  7. Acute Kidney Injury and Mortality in Hospitalized Patients

    著者: , , , - American Journal of Nephrology 2012 被引用: 543

  8. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Solfrid Romundstad, Knut Aasarød, Cecilia Montgomery Øien, Stein Hallan, David H. Smith, Micah L. Thorp, Eric S. Johnson, Gabriel Chodick, Esma Herzel, Rachel Katz, Varda Shalev, Ron T. Gansevoort, Stephan J. L. Bakker, Hiddo J. Lambers Heerspink, Pim van der Harst, Sun Ha Jee, Heejin Kimm, Yejin Mok, Navdeep Tangri, David Naimark, Johan Ärnlöv, Anders Larsson, Lars Lannfelt, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh, Josef Coresh, Morgan E. Grams, Kunihiro Matsushita, Ron T. Gansevoort, Paul E. de Jong, Kunitoshi Iseki, Andrew S. Levey, Mark J. Sarnak, Bénédicte Stengel, David G. Warnock, Mark Woodward, Shoshana H. Ballew, Josef Coresh, Morgan E. Grams, Kunihiro Matsushita, Yingying Sang, Mark Woodward - American Journal of Kidney Diseases 2015 被引用: 309

  9. Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease

    著者: , , , , , , , , , , , , , - Journal of Medical Genetics 2015 被引用: 364

  10. Global Cardiovascular and Renal Outcomes of Reduced GFR

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ron T. Gansevoort, Philimon N. Gona, Orlando M. Gutierrez, Samer Hamidi, Sarah Wulf Hanson, Jonathan Himmelfarb, Simerjot K. Jassal, Sun Ha Jee, Vivekanand Jha, Aida Jimenez-Corona, Jost B. Jonas, Andre Pascal Kengne, Yousef Khader, Young-Ho Khang, Yun Jin Kim, Barbara Klein, Ronald Klein, Yoshihiro Kokubo, Dhaval Kolte, Kristine Lee, Andrew S. Levey, Yongmei Li, Paulo Lotufo, Hassan Magdy Abd El Razek, Walter Mendoza, Hirohito Metoki, Yejin Mok, Isao Muraki, Paul M. Muntner, Hiroyuki Noda, Takayoshi Ohkubo, Alberto Ortiz, Norberto Perico, Kevan Polkinghorne, Rajaa Al-Radaddi, Giuseppe Remuzzi, Gregory Roth, Dietrich Rothenbacher, Michihiro Satoh, Kai-Uwe Saum, Monika Sawhney, Ben Schöttker, Anoop Shankar, Michael Shlipak, Diego Augusto Santos Silva, Hideaki Toyoshima, Kingsley Ukwaja, Mitsumasa Umesawa, Stein Emil Vollset, David G. Warnock, Andrea Werdecker, Kazumasa Yamagishi, Yuichiro Yano, Naohiro Yonemoto, Maysaa El Sayed Zaki, Mohsen Naghavi, Mohammad H. Forouzanfar, Christopher J.L. Murray, Josef Coresh, Theo Vos, on behalf of the Global Burden of Disease 2013 GFR Collaborators, Global Burden of Disease Genitourinary Expert Group - Journal of the American Society of Nephrology 2017 被引用: 275

  11. Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

    著者: , , , , , , , , - American Journal of Kidney Diseases 2008 被引用: 385

  12. Agalsidase-Beta Therapy for Advanced Fabry Disease

    著者: , , , , , , , , , , - Annals of Internal Medicine 2007 被引用: 566

  13. A new approach to identifying patients with elevated risk for Fabry disease using a machine learning algorithm

    著者: , , , , , , , , , - Orphanet Journal of Rare Diseases 2021 被引用: 46

  14. Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , João Paulo Oliveira, Antonio Pisani, Juan Politei, Uma Ramaswami, Markus Ries, Wim Terryn, Camilla Tøndel, Roser Torrá, Bojan Vujkovac, Stephen Waldek, Jerry Walter - Kidney International 2016 被引用: 188

  15. Design of Clinical Trials in Acute Kidney Injury

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sudhir V. Shah, Yining Xie, Emily G. Duggan, Paul L. Kimmel, Robert A. Star - Clinical Journal of the American Society of Nephrology 2012 被引用: 188

  16. Global Cardiovascular and Renal Outcomes of Reduced GFR

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ron T. Gansevoort, Philimon Gona, Orlando M. Gutiérrez, Samer Hamidi, Sarah Wulf Hanson, Jonathan Himmelfarb, Simerjot K Jassal, Sun Ha Jee, Vivekanand Jha, Aída Jiménez-Corona, Jost B. Jonas, André Pascal Kengne, Yousef Khader, Young‐Ho Khang, Yun Jin Kim, Barbara E.K. Klein, Ronald Klein, Yoshihiro Kokubo, Dhaval Kolte, Kristine Lee, Andrew S. Levey, Yongmei Li, Paulo A. Lotufo, Hassan Magdy Abd El Razek, Walter Mendoza, Hirohito Metoki, Yejin Mok, Isao Muraki, Paul Muntner, Hiroyuki Noda, Takayoshi Ohkubo, Alberto Ortíz, Norberto Perico, Kevan R. Polkinghorne, Rajaa Al-Radaddi, Giuseppe Remuzzi, Gregory A. Roth, Dietrich Rothenbacher, Michihiro Satoh, Kai‐Uwe Saum, Monika Sawhney, Schoettker, B, Anoop Shankar, Michael Shlipak, Diego Augusto Santos Silva, Hideaki Toyoshima, Kingsley Nnanna Ukwaja, Mitsumasa Umesawa, Vollset, SE, David G. Warnock, Andrea Werdecker, Kazumasa Yamagishi, Yuichiro Yano, Naohiro Yonemoto, Maysaa El Sayed Zaki, Mohsen Naghavi, Mohammad H. Forouzanfar, Christopher J L Murray, Josef Coresh, Theo Vos - 2017 被引用: 184

  17. Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry

    著者: , , , , , , , , , , , , , , , , , - Journal of Medical Genetics 2016 被引用: 147

  18. Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry

    著者: , , , , , , , , , , , , , , , , , - Molecular Genetics and Metabolism 2007 被引用: 539

  19. Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy

    著者: , , , , , , , , - Nephrology Dialysis Transplantation 2009 被引用: 366

  20. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert M. Perkins, Alex R. Chang, Solfrid Romundstad, Knut Aasarød, Cecilia Montgomery Øien, Stein Hallan, David H. Smith, Micah L. Thorp, Eric S. Johnson, Gabriel Chodick, Esma Herzel, Rachel Katz, Varda Shalev, Ron T. Gansevoort, Stephan J. L. Bakker, Hiddo J.L. Heerspink, Pim van der Harst, Sun Ha Jee, Heejin Kimm, Yejin Mok, Navdeep Tangri, David Naimark, Johan Ärnlöv, Anders Larsson, Lars Lannfelt, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh, Josef Coresh, Morgan E. Grams, Kunihiro Matsushita, Ron T. Gansevoort, Paul E. de Jong, Kunitoshi Iseki, Andrew S. Levey, Mark J. Sarnak, Bénédicte Stengel, David G. Warnock, Mark Woodward, Shoshana H. Ballew, Josef Coresh, Morgan E. Grams, Kunihiro Matsushita, Yingying Sang, Mark Woodward - American Journal of Kidney Diseases 2015 被引用: 225

  21. Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

    著者: , , , , , , , , , , , - American Journal of Nephrology 2018 被引用: 161

  22. Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel

    著者: , , , , , , , , , , , , - Cell 1994 被引用: 1,264

  23. Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement

    著者: , , , , , , , , , , , , - Genetics in Medicine 2006 被引用: 417

  24. Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry disease

    著者: , , , , - Journal of Medical Genetics 2021 被引用: 66